The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study

Author(s):
Steenwijk, P.J.D. van; Poelgeest, M.I.E. van; Ramwadhdoebe, T.H.; Lowik, M.J.G.; Berends-van der Meer, D.M.A.; Minne, C.E. van der; Loof, N.M.; Stynenbosch, L.F.M.; Fathers, L.M.; Valentijn, A.R.P.M.; Oostendorp, J.; Osse, E.M.; Fleuren, G.J. (0000-0002-9276-183X); Nooij, L.; Kagie, M.J.; Hellebrekers, B.W.J.; Melief, C.J.M.; Welters, M.J.P.; Burg, S.H. van der (0000-0002-6556-0354); Kenter, G.G.
Published
2014
Publication type
Article / Letter to editor
CINHPV16ImmunotherapyVaccinationMemory response
Date issued
2014-02-28
Language
English
Is part of
Cancer Immunology, Immunotherapy (2014), Vol. 63, no. 2, p. 147-160
hdl
1887/107130
doi
10.1007/s00262-013-1499-2